Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

An Evaluation of the Proposed Worker Protection Standard with Respect to Pesticide Exposure and Parkinson's Disease.

Sparling AS, Martin DW, Posey LB.

Int J Environ Res Public Health. 2017 Jun 14;14(6). pii: E640. doi: 10.3390/ijerph14060640.

2.

Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.

Hill-Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR, Wallen ZD, Peddada SD, Factor SA, Molho E, Zabetian CP, Knight R, Payami H.

Mov Disord. 2017 May;32(5):739-749. doi: 10.1002/mds.26942. Epub 2017 Feb 14.

PMID:
28195358
3.

Assessment of the Effects of MPTP and Paraquat on Dopaminergic Neurons and Microglia in the Substantia Nigra Pars Compacta of C57BL/6 Mice.

Smeyne RJ, Breckenridge CB, Beck M, Jiao Y, Butt MT, Wolf JC, Zadory D, Minnema DJ, Sturgess NC, Travis KZ, Cook AR, Smith LL, Botham PA.

PLoS One. 2016 Oct 27;11(10):e0164094. doi: 10.1371/journal.pone.0164094. eCollection 2016.

4.

Neurotoxicity of the Parkinson Disease-Associated Pesticide Ziram Is Synuclein-Dependent in Zebrafish Embryos.

Lulla A, Barnhill L, Bitan G, Ivanova MI, Nguyen B, O'Donnell K, Stahl MC, Yamashiro C, Klärner FG, Schrader T, Sagasti A, Bronstein JM.

Environ Health Perspect. 2016 Nov;124(11):1766-1775. Epub 2016 Jun 15.

5.

MPTP neurotoxicity is highly concordant between the sexes among BXD recombinant inbred mouse strains.

Alam G, Miller DB, O'Callaghan JP, Lu L, Williams RW, Jones BC.

Neurotoxicology. 2016 Jul;55:40-47. doi: 10.1016/j.neuro.2016.04.008. Epub 2016 May 12.

6.

Association between Parkinson's Disease and Cigarette Smoking, Rural Living, Well-Water Consumption, Farming and Pesticide Use: Systematic Review and Meta-Analysis.

Breckenridge CB, Berry C, Chang ET, Sielken RL Jr, Mandel JS.

PLoS One. 2016 Apr 7;11(4):e0151841. doi: 10.1371/journal.pone.0151841. eCollection 2016. Review.

7.

Environmental and occupational risk factors for progressive supranuclear palsy: Case-control study.

Litvan I, Lees PS, Cunningham CR, Rai SN, Cambon AC, Standaert DG, Marras C, Juncos J, Riley D, Reich S, Hall D, Kluger B, Bordelon Y, Shprecher DR; for ENGENE-PSP.

Mov Disord. 2016 May;31(5):644-52. doi: 10.1002/mds.26512. Epub 2016 Feb 8.

8.

Protective Mechanisms of Flavonoids in Parkinson's Disease.

Magalingam KB, Radhakrishnan AK, Haleagrahara N.

Oxid Med Cell Longev. 2015;2015:314560. doi: 10.1155/2015/314560. Epub 2015 Oct 20. Review.

9.

Genetic variability in ABCB1, occupational pesticide exposure, and Parkinson's disease.

Narayan S, Sinsheimer JS, Paul KC, Liew Z, Cockburn M, Bronstein JM, Ritz B.

Environ Res. 2015 Nov;143(Pt A):98-106. doi: 10.1016/j.envres.2015.08.022. Epub 2015 Oct 19.

10.

P-Glycoprotein Transport of Neurotoxic Pesticides.

Lacher SE, Skagen K, Veit J, Dalton R, Woodahl EL.

J Pharmacol Exp Ther. 2015 Oct;355(1):99-107. doi: 10.1124/jpet.115.226373. Epub 2015 Aug 13.

11.
12.

Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases.

Chin-Chan M, Navarro-Yepes J, Quintanilla-Vega B.

Front Cell Neurosci. 2015 Apr 10;9:124. doi: 10.3389/fncel.2015.00124. eCollection 2015. Review.

13.

Toxicogenetics: in search of host susceptibility to environmental toxicants.

Alam G, Jones BC.

Front Genet. 2014 Sep 22;5:327. doi: 10.3389/fgene.2014.00327. eCollection 2014. Review.

14.

Role of early life exposure and environment on neurodegeneration: implications on brain disorders.

Modgil S, Lahiri DK, Sharma VL, Anand A.

Transl Neurodegener. 2014 Apr 29;3:9. doi: 10.1186/2047-9158-3-9. eCollection 2014. Review.

15.

Requiring pollutant discharge permits for pesticide applications that deposit residues in surface waters.

Centner T, Eberhart N.

Int J Environ Res Public Health. 2014 May 8;11(5):4978-90. doi: 10.3390/ijerph110504978.

16.

The perplexing paradox of paraquat: the case for host-based susceptibility and postulated neurodegenerative effects.

Jones BC, Huang X, Mailman RB, Lu L, Williams RW.

J Biochem Mol Toxicol. 2014 May;28(5):191-7. doi: 10.1002/jbt.21552. Epub 2014 Mar 5. Review.

17.

Orally delivered water soluble Coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson's disease.

Muthukumaran K, Leahy S, Harrison K, Sikorska M, Sandhu JK, Cohen J, Keshan C, Lopatin D, Miller H, Borowy-Borowski H, Lanthier P, Weinstock S, Pandey S.

BMC Neurosci. 2014 Jan 31;15:21. doi: 10.1186/1471-2202-15-21.

18.

The vesicular monoamine transporter 2: an underexplored pharmacological target.

Bernstein AI, Stout KA, Miller GW.

Neurochem Int. 2014 Jul;73:89-97. doi: 10.1016/j.neuint.2013.12.003. Epub 2014 Jan 4. Review.

19.

Elevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in Parkinson's disease.

Louis ED, Michalec M, Jiang W, Factor-Litvak P, Zheng W.

Neurotoxicology. 2014 Jan;40:52-6. doi: 10.1016/j.neuro.2013.11.005. Epub 2013 Dec 1.

20.

Absence of P-glycoprotein transport in the pharmacokinetics and toxicity of the herbicide paraquat.

Lacher SE, Gremaud JN, Skagen K, Steed E, Dalton R, Sugden KD, Cardozo-Pelaez F, Sherwin CM, Woodahl EL.

J Pharmacol Exp Ther. 2014 Feb;348(2):336-45. doi: 10.1124/jpet.113.209791. Epub 2013 Dec 2.

Supplemental Content

Support Center